Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. CDI @ TMC QuickFire Challenge

    to $400,000 USD* Focus:  Cardiovascular Obesity Osteoarthritis Surgical Oncology Detail URL:  Learn more ... Devices, with an emphasis on Surgical Oncology and/or Obesity. Johnson & Johnson Innovation will award ... This QuickFire Challenge is looking for companies with a focus on Surgical Oncology and / or Obesity, however, ...

  2. New Immuno-Oncology Lung Cancer Collaboration Launched with Dana-Farber’s Belfer Institute; One of Seven New Strategic Oncology Partnerships

    Head, Oncology Today we announced a three-year collaboration with the Dana-Faber Cancer Institute’s ... to benefit from a new generation of immuno-oncology therapies.  This agreement is one of seven new strategic ... oncology collaborations that we’ve recently announced, including a lymphoma program with Weill Cornell ...

  3. Meet Ibraheem Badejo, PhD, Senior Director, New Ventures, Medical Devices

    in the medical device landscape? Surgical oncology and surgical robotics are very hot right now. There is also ... and orthopedics with an emphasis on surgical oncology, obesity, osteoarthritis and osteoporosis, as well ... specific challenges and bring forth innovative solutions. For example, currently in surgical oncology ...

  4. Poseida

    be surgically precise. Poseida aims to shuttle the first CAR-T and gene therapy product candidates into Phase ... I clinical trials in early 2016. JLABS @ San Diego Oncology 1 Wednesday, April 1, 2015 Saturday, March 25, ...

  5. Science First: Surgery Robotics

    ;/span> Eventbrite last changed:  Sunday, November 20, 2016- 12:32 Event description:  Surgical robotics has ... attracted considerable media attention in recent years and Intuitive Surgical, maker of the only ... commercialized robotic general surgical platform, has experienced remarkable growth. Nevertheless, robotics ...

  6. Science 1st- Evolving treatment paradigm: The convergence of targeted therapy and immunotherapy in oncology

    S. Grewal | Vice President, Head of Immuno-Oncology, Janssen Research & Development, LLC read ... bio» Kim Margolin | Adjunct Clinical Professor of Medical Oncology, Stanford University read bio» Kevan ... | Vice President, Oncology Scientific Innovation, Johnson & Johnson Innovation read bio» Fees: $25 ...

  7. Science First: Immuno-Oncology

    ;span>https://www.eventbrite.com/e/science-first-immuno-oncology-tickets-18973396941< ... immunotherapies and combination regimens of the future. Speakers: Arturo Molina | Vice President, Oncology ... President, Head of Immuno-Oncology, Johnson & Johnson read bio» John Heymach | Chair and Professor, Depts ...

  8. Science First: Immuno-Oncology

    <span>https://www.eventbrite.com/e/science-first-immuno-oncology-tickets-19639297668< ... immunotherapies and combination regimens of the future. Speakers: Arturo Molina | Vice President, Oncology ... President, Head of Immuno-Oncology, Johnson & Johnson read bio» John Heymach | Chair and Professor, Depts ...

  9. Science 1st- Oncology: Harnessing Cancer Immunotherapies of the Future

    <span>https://www.eventbrite.com/e/science-1st-oncology ... and is board certified in medical oncology and internal medicine. Her laboratory is focused on defining ... Oncology in 2001. ^ Back to Speakers' list ^ [moderator] Kathryn Packman, Ph.D. | Scientific Director ...

  10. Spotlight on JLABS- Oncology

    <span>https://www.eventbrite.com/e/spotlight-on-jlabs-oncology-tickets-42295904188< ... emerging companies? On February 22nd, JLABS will shine the spotlight on our Oncology companies that have ... Pharmaceuticals | Jonathan Northrup, Chief Executive Officer Beta Cat is a phase 1 oncology company developing ...

Pages

Share